Jim Robbins

Micrus Endovascular LLC operated as a medical device company. The company was founded in June 1996 and was headquartered in San Jose, CA.

Genitope Corp. operates as a biotechnology company, which focuses on the research and development of novel immunotherapies for the treatment of cancer. The company was founded on August 15, 1996 and is headquartered in Redwood, CA.

Peregrine Extricity, Inc. is a provider of business-to-business (B2B) software products that allow companies to manage the internal and external sharing of information and the execution of interactions among software applications and business partners over the Internet. It refers to this exchange and management of information among groups of companies over the Internet as business-to-business relationship management, or B2BRM. The company is headquartered in Belmont, CA.

InVision Technologies, Inc. and its subsidiaries develop, manufacture, market and support explosives detection systems based on advanced computed tomography technology, X-ray diffraction and quadrupole resonance. The company is the leading supplier of explosives detection systems to the U.S. government for civil aviation security. The company is headquartered in Newark, CA

Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA.